- Title
- Maryland Department of Health - Reports on Standing Orders and Opioid Overdose Reversal Drugs
- Sponsored by
- Senator Klausmeier
- Status
- Approved by the Governor - Chapter 849
- Analysis
- Fiscal and Policy Note (Revised)
Synopsis
Requiring the Maryland Department of Health to report, on or before December 1, 2024, December 1, 2025, and December 1, 2026, to the Senate Finance Committee and the House Health and Government Operations Committee on current opioid overdose reversal drugs approved by the federal Food and Drug Administration and, for any approved opioid overdose reversal drug, whether the Department has added the drug to a standing order and, if not, the reasons why the drug has not been added.
Committees
- Original:
- Finance Click to view Recorded Media
- Opposite:
- Health and Government Operations
Committee Testimony
Details
History
Toggle History Dropdown
File Code
Toggle Filecode Dropdown
Subjects
Toggle Subjects Dropdown
Statutes
Last Updated: 5/23/2024 4:37 PM